426 related articles for article (PubMed ID: 8238468)
1. Arginine vasopressin produces renal vasodilation via V2 receptors in conscious dogs.
Naitoh M; Suzuki H; Murakami M; Matsumoto A; Ichihara A; Nakamoto H; Yamamura Y; Saruta T
Am J Physiol; 1993 Oct; 265(4 Pt 2):R934-42. PubMed ID: 8238468
[TBL] [Abstract][Full Text] [Related]
2. Effects of oral AVP receptor antagonists OPC-21268 and OPC-31260 on congestive heart failure in conscious dogs.
Naitoh M; Suzuki H; Murakami M; Matsumoto A; Arakawa K; Ichihara A; Nakamoto H; Oka K; Yamamura Y; Saruta T
Am J Physiol; 1994 Dec; 267(6 Pt 2):H2245-54. PubMed ID: 7810724
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide may participate in V2 vasopressin-receptor-mediated renal vasodilation.
Aki Y; Tamaki T; Kiyomoto H; He H; Yoshida H; Iwao H; Abe Y
J Cardiovasc Pharmacol; 1994 Feb; 23(2):331-6. PubMed ID: 7511766
[TBL] [Abstract][Full Text] [Related]
4. Blocking effects of V1 (OPC-21268) and V2 (OPC-31260) antagonists on the negative inotropic response to vasopressin in isolated dog heart preparations.
Furukawa Y; Takayama S; Ren LM; Sawaki S; Inoue Y; Chiba S
J Pharmacol Exp Ther; 1992 Nov; 263(2):627-31. PubMed ID: 1331408
[TBL] [Abstract][Full Text] [Related]
5. Vasodilation induced by vasopressin V2 receptor stimulation in afferent arterioles.
Tamaki T; Kiyomoto K; He H; Tomohiro A; Nishiyama A; Aki Y; Kimura S; Abe Y
Kidney Int; 1996 Mar; 49(3):722-9. PubMed ID: 8648913
[TBL] [Abstract][Full Text] [Related]
6. Effects of receptor blockade on metabolism and renal actions of vasopressin in conscious dogs.
Grove L; Christensen P; Bie P
Acta Physiol Scand; 1998 May; 163(1):93-101. PubMed ID: 9648627
[TBL] [Abstract][Full Text] [Related]
7. In vivo diuretic effect of a new non-peptide arginine vasopressin antagonist, OPC-31260, in conscious rats.
Tsuboi Y; Ishikawa S; Fujisawa G; Okada K; Saito T
J Endocrinol; 1994 Nov; 143(2):227-34. PubMed ID: 7829988
[TBL] [Abstract][Full Text] [Related]
8. Enhanced renal vasoconstriction induced by vasopressin in SHR is mediated by V1 receptors.
Feng JJ; Arendshorst WJ
Am J Physiol; 1996 Aug; 271(2 Pt 2):F304-13. PubMed ID: 8770161
[TBL] [Abstract][Full Text] [Related]
9. V2 receptor antagonism of DDAVP-induced release of hemostasis factors in conscious dogs.
Bernat A; Hoffmann P; Dumas A; Serradeil-le Gal C; Raufaste D; Herbert JM
J Pharmacol Exp Ther; 1997 Aug; 282(2):597-602. PubMed ID: 9262320
[TBL] [Abstract][Full Text] [Related]
10. Vasopressin-mediated forearm vasodilation in normal humans. Evidence for a vascular vasopressin V2 receptor.
Hirsch AT; Dzau VJ; Majzoub JA; Creager MA
J Clin Invest; 1989 Aug; 84(2):418-26. PubMed ID: 2527249
[TBL] [Abstract][Full Text] [Related]
11. Vascular effects alter early-gestation fetal renal responses to vasopressin.
Ervin MG; Terry KA; Calvario GC; Castro R; Ross MG; Leake RD; Fisher DA
Am J Physiol; 1994 Mar; 266(3 Pt 2):R722-9. PubMed ID: 8160865
[TBL] [Abstract][Full Text] [Related]
12. Renal versus hindquarter hemodynamic responses to vasopressin in conscious rats.
Harrison-Bernard LM; Brizzee BL; Clifton GG; Walker BR
J Cardiovasc Pharmacol; 1990 Nov; 16(5):719-26. PubMed ID: 1703592
[TBL] [Abstract][Full Text] [Related]
13. In vivo diuretic actions of renal vasopressin V1 receptor stimulation in rats.
Ledderhos C; Mattson DL; Skelton MM; Cowley AW
Am J Physiol; 1995 Mar; 268(3 Pt 2):R796-807. PubMed ID: 7900923
[TBL] [Abstract][Full Text] [Related]
14. Effect of vasopressin V (OPC-21268) and V2 (OPC-31260) antagonists on renal hemodynamics and excretory function.
Nakamura T; Sakamaki T; Kurashina T; Hoshino J; Sato K; Ono Z; Murata K
Life Sci; 1994; 55(4):PL67-72. PubMed ID: 8028441
[TBL] [Abstract][Full Text] [Related]
15. Interaction between V1 and V2 effects in hemodynamic response to vasopressin in dogs.
Liard JF
Am J Physiol; 1990 Feb; 258(2 Pt 2):H482-9. PubMed ID: 2137987
[TBL] [Abstract][Full Text] [Related]
16. cAMP and extrarenal vasopressin V2 receptors in dogs.
Liard JF
Am J Physiol; 1992 Dec; 263(6 Pt 2):H1888-91. PubMed ID: 1336316
[TBL] [Abstract][Full Text] [Related]
17. L-NAME antagonizes vasopressin V2-induced vasodilatation in dogs.
Liard JF
Am J Physiol; 1994 Jan; 266(1 Pt 2):H99-106. PubMed ID: 8304528
[TBL] [Abstract][Full Text] [Related]
18. V2 receptor-mediated vasodilation in healthy humans.
Tagawa T; Imaizumi T; Shiramoto M; Endo T; Hironaga K; Takeshita A
J Cardiovasc Pharmacol; 1995 Mar; 25(3):387-92. PubMed ID: 7769802
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of vasopressin natriuresis in the dog: role of vasopressin receptors and prostaglandins.
Kompanowska-Jezierska E; Emmeluth C; Grove L; Christensen P; Sadowski J; Bie P
Am J Physiol; 1998 Jun; 274(6):R1619-25. PubMed ID: 9608016
[TBL] [Abstract][Full Text] [Related]
20. Effects of V1- and V2-vasopressin (AVP) antagonists on the pressor, AVP and atrial natriuretic peptide responses to a hypertonic saline infusion in conscious anephric rats.
Ota K; Kimura T; Inoue M; Funyu T; Shoji M; Sato K; Ohta M; Yamamoto T; Abe K
Eur J Endocrinol; 1995 Jul; 133(1):127-32. PubMed ID: 7627334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
